Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B and C Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B and C Diagnostics. This report contains market size and forecasts of Hepatitis B and C Diagnostics in global, including the following market information:
Global Hepatitis B and C Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Hepatitis B and C Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.
We surveyed the Hepatitis B and C Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B and C Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Hepatitis B and C Diagnostics Market Segment Percentages, by Type, 2022 (%)
Hepatitis B
Hepatitis C
Global Hepatitis B and C Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Hepatitis B and C Diagnostics Market Segment Percentages, by Application, 2022 (%)
Immunodiagnostics
Nucleic Acid Test (NAT)
Global Hepatitis B and C Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Hepatitis B and C Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B and C Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hepatitis B and C Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Diagnostics
Abbott
Siemens
Qiagen
Abbott
bioM?rieux
Cepheid
Chembio Diagnostics
DiaSorin
Enzo Life Sciences
Hologic
MedMira
OraSure Technologies
Quest Diagnostics
Quidel Corp
Randox Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hepatitis B and C Diagnostics, market overview.
Chapter 2: Global Hepatitis B and C Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Hepatitis B and C Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hepatitis B and C Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis B and C Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis B and C Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis B and C Diagnostics Overall Market Size
2.1 Global Hepatitis B and C Diagnostics Market Size: 2022 VS 2029
2.2 Global Hepatitis B and C Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hepatitis B and C Diagnostics Players in Global Market
3.2 Top Global Hepatitis B and C Diagnostics Companies Ranked by Revenue
3.3 Global Hepatitis B and C Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Hepatitis B and C Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hepatitis B and C Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hepatitis B and C Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Hepatitis B and C Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hepatitis B and C Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis B and C Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Hepatitis B
4.1.3 Hepatitis C
4.2 By Type - Global Hepatitis B and C Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Hepatitis B and C Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Hepatitis B and C Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis B and C Diagnostics Market Size, 2022 & 2029
5.1.2 Immunodiagnostics
5.1.3 Nucleic Acid Test (NAT)
5.2 By Application - Global Hepatitis B and C Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Hepatitis B and C Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Hepatitis B and C Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hepatitis B and C Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Hepatitis B and C Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Hepatitis B and C Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Hepatitis B and C Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hepatitis B and C Diagnostics Revenue, 2018-2029
6.3.2 US Hepatitis B and C Diagnostics Market Size, 2018-2029
6.3.3 Canada Hepatitis B and C Diagnostics Market Size, 2018-2029
6.3.4 Mexico Hepatitis B and C Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hepatitis B and C Diagnostics Revenue, 2018-2029
6.4.2 Germany Hepatitis B and C Diagnostics Market Size, 2018-2029
6.4.3 France Hepatitis B and C Diagnostics Market Size, 2018-2029
6.4.4 U.K. Hepatitis B and C Diagnostics Market Size, 2018-2029
6.4.5 Italy Hepatitis B and C Diagnostics Market Size, 2018-2029
6.4.6 Russia Hepatitis B and C Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Hepatitis B and C Diagnostics Market Size, 2018-2029
6.4.8 Benelux Hepatitis B and C Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hepatitis B and C Diagnostics Revenue, 2018-2029
6.5.2 China Hepatitis B and C Diagnostics Market Size, 2018-2029
6.5.3 Japan Hepatitis B and C Diagnostics Market Size, 2018-2029
6.5.4 South Korea Hepatitis B and C Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Hepatitis B and C Diagnostics Market Size, 2018-2029
6.5.6 India Hepatitis B and C Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hepatitis B and C Diagnostics Revenue, 2018-2029
6.6.2 Brazil Hepatitis B and C Diagnostics Market Size, 2018-2029
6.6.3 Argentina Hepatitis B and C Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hepatitis B and C Diagnostics Revenue, 2018-2029
6.7.2 Turkey Hepatitis B and C Diagnostics Market Size, 2018-2029
6.7.3 Israel Hepatitis B and C Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Hepatitis B and C Diagnostics Market Size, 2018-2029
6.7.5 UAE Hepatitis B and C Diagnostics Market Size, 2018-2029
7 Hepatitis B and C Diagnostics Companies Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Company Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Hepatitis B and C Diagnostics Major Product Offerings
7.1.4 Roche Diagnostics Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Roche Diagnostics Key News & Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Hepatitis B and C Diagnostics Major Product Offerings
7.2.4 Abbott Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News & Latest Developments
7.3 Siemens
7.3.1 Siemens Company Summary
7.3.2 Siemens Business Overview
7.3.3 Siemens Hepatitis B and C Diagnostics Major Product Offerings
7.3.4 Siemens Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Siemens Key News & Latest Developments
7.4 Qiagen
7.4.1 Qiagen Company Summary
7.4.2 Qiagen Business Overview
7.4.3 Qiagen Hepatitis B and C Diagnostics Major Product Offerings
7.4.4 Qiagen Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Qiagen Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Hepatitis B and C Diagnostics Major Product Offerings
7.5.4 Abbott Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Abbott Key News & Latest Developments
7.6 bioM?rieux
7.6.1 bioM?rieux Company Summary
7.6.2 bioM?rieux Business Overview
7.6.3 bioM?rieux Hepatitis B and C Diagnostics Major Product Offerings
7.6.4 bioM?rieux Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.6.5 bioM?rieux Key News & Latest Developments
7.7 Cepheid
7.7.1 Cepheid Company Summary
7.7.2 Cepheid Business Overview
7.7.3 Cepheid Hepatitis B and C Diagnostics Major Product Offerings
7.7.4 Cepheid Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Cepheid Key News & Latest Developments
7.8 Chembio Diagnostics
7.8.1 Chembio Diagnostics Company Summary
7.8.2 Chembio Diagnostics Business Overview
7.8.3 Chembio Diagnostics Hepatitis B and C Diagnostics Major Product Offerings
7.8.4 Chembio Diagnostics Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Chembio Diagnostics Key News & Latest Developments
7.9 DiaSorin
7.9.1 DiaSorin Company Summary
7.9.2 DiaSorin Business Overview
7.9.3 DiaSorin Hepatitis B and C Diagnostics Major Product Offerings
7.9.4 DiaSorin Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.9.5 DiaSorin Key News & Latest Developments
7.10 Enzo Life Sciences
7.10.1 Enzo Life Sciences Company Summary
7.10.2 Enzo Life Sciences Business Overview
7.10.3 Enzo Life Sciences Hepatitis B and C Diagnostics Major Product Offerings
7.10.4 Enzo Life Sciences Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Enzo Life Sciences Key News & Latest Developments
7.11 Hologic
7.11.1 Hologic Company Summary
7.11.2 Hologic Business Overview
7.11.3 Hologic Hepatitis B and C Diagnostics Major Product Offerings
7.11.4 Hologic Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Hologic Key News & Latest Developments
7.12 MedMira
7.12.1 MedMira Company Summary
7.12.2 MedMira Business Overview
7.12.3 MedMira Hepatitis B and C Diagnostics Major Product Offerings
7.12.4 MedMira Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.12.5 MedMira Key News & Latest Developments
7.13 OraSure Technologies
7.13.1 OraSure Technologies Company Summary
7.13.2 OraSure Technologies Business Overview
7.13.3 OraSure Technologies Hepatitis B and C Diagnostics Major Product Offerings
7.13.4 OraSure Technologies Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.13.5 OraSure Technologies Key News & Latest Developments
7.14 Quest Diagnostics
7.14.1 Quest Diagnostics Company Summary
7.14.2 Quest Diagnostics Business Overview
7.14.3 Quest Diagnostics Hepatitis B and C Diagnostics Major Product Offerings
7.14.4 Quest Diagnostics Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.14.5 Quest Diagnostics Key News & Latest Developments
7.15 Quidel Corp
7.15.1 Quidel Corp Company Summary
7.15.2 Quidel Corp Business Overview
7.15.3 Quidel Corp Hepatitis B and C Diagnostics Major Product Offerings
7.15.4 Quidel Corp Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.15.5 Quidel Corp Key News & Latest Developments
7.16 Randox Laboratories
7.16.1 Randox Laboratories Company Summary
7.16.2 Randox Laboratories Business Overview
7.16.3 Randox Laboratories Hepatitis B and C Diagnostics Major Product Offerings
7.16.4 Randox Laboratories Hepatitis B and C Diagnostics Revenue in Global Market (2018-2023)
7.16.5 Randox Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hepatitis B and C Diagnostics Market Opportunities & Trends in Global Market
Table 2. Hepatitis B and C Diagnostics Market Drivers in Global Market
Table 3. Hepatitis B and C Diagnostics Market Restraints in Global Market
Table 4. Key Players of Hepatitis B and C Diagnostics in Global Market
Table 5. Top Hepatitis B and C Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hepatitis B and C Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hepatitis B and C Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hepatitis B and C Diagnostics Product Type
Table 9. List of Global Tier 1 Hepatitis B and C Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B and C Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Hepatitis B and C Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hepatitis B and C Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Hepatitis B and C Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hepatitis B and C Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Hepatitis B and C Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hepatitis B and C Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. Roche Diagnostics Company Summary
Table 31. Roche Diagnostics Hepatitis B and C Diagnostics Product Offerings
Table 32. Roche Diagnostics Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Diagnostics Key News & Latest Developments
Table 34. Abbott Company Summary
Table 35. Abbott Hepatitis B and C Diagnostics Product Offerings
Table 36. Abbott Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Key News & Latest Developments
Table 38. Siemens Company Summary
Table 39. Siemens Hepatitis B and C Diagnostics Product Offerings
Table 40. Siemens Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Siemens Key News & Latest Developments
Table 42. Qiagen Company Summary
Table 43. Qiagen Hepatitis B and C Diagnostics Product Offerings
Table 44. Qiagen Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Qiagen Key News & Latest Developments
Table 46. Abbott Company Summary
Table 47. Abbott Hepatitis B and C Diagnostics Product Offerings
Table 48. Abbott Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. bioM?rieux Company Summary
Table 51. bioM?rieux Hepatitis B and C Diagnostics Product Offerings
Table 52. bioM?rieux Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. bioM?rieux Key News & Latest Developments
Table 54. Cepheid Company Summary
Table 55. Cepheid Hepatitis B and C Diagnostics Product Offerings
Table 56. Cepheid Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Cepheid Key News & Latest Developments
Table 58. Chembio Diagnostics Company Summary
Table 59. Chembio Diagnostics Hepatitis B and C Diagnostics Product Offerings
Table 60. Chembio Diagnostics Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Chembio Diagnostics Key News & Latest Developments
Table 62. DiaSorin Company Summary
Table 63. DiaSorin Hepatitis B and C Diagnostics Product Offerings
Table 64. DiaSorin Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. DiaSorin Key News & Latest Developments
Table 66. Enzo Life Sciences Company Summary
Table 67. Enzo Life Sciences Hepatitis B and C Diagnostics Product Offerings
Table 68. Enzo Life Sciences Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Enzo Life Sciences Key News & Latest Developments
Table 70. Hologic Company Summary
Table 71. Hologic Hepatitis B and C Diagnostics Product Offerings
Table 72. Hologic Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Hologic Key News & Latest Developments
Table 74. MedMira Company Summary
Table 75. MedMira Hepatitis B and C Diagnostics Product Offerings
Table 76. MedMira Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 77. MedMira Key News & Latest Developments
Table 78. OraSure Technologies Company Summary
Table 79. OraSure Technologies Hepatitis B and C Diagnostics Product Offerings
Table 80. OraSure Technologies Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 81. OraSure Technologies Key News & Latest Developments
Table 82. Quest Diagnostics Company Summary
Table 83. Quest Diagnostics Hepatitis B and C Diagnostics Product Offerings
Table 84. Quest Diagnostics Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 85. Quest Diagnostics Key News & Latest Developments
Table 86. Quidel Corp Company Summary
Table 87. Quidel Corp Hepatitis B and C Diagnostics Product Offerings
Table 88. Quidel Corp Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 89. Quidel Corp Key News & Latest Developments
Table 90. Randox Laboratories Company Summary
Table 91. Randox Laboratories Hepatitis B and C Diagnostics Product Offerings
Table 92. Randox Laboratories Hepatitis B and C Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 93. Randox Laboratories Key News & Latest Developments
List of Figures
Figure 1. Hepatitis B and C Diagnostics Segment by Type in 2022
Figure 2. Hepatitis B and C Diagnostics Segment by Application in 2022
Figure 3. Global Hepatitis B and C Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis B and C Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hepatitis B and C Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hepatitis B and C Diagnostics Revenue in 2022
Figure 8. By Type - Global Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Hepatitis B and C Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Hepatitis B and C Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Diagnostics Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Siemens Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Qiagen Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. bioM?rieux Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cepheid Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Chembio Diagnostics Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. DiaSorin Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Enzo Life Sciences Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hologic Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. MedMira Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. OraSure Technologies Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Quest Diagnostics Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Quidel Corp Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Randox Laboratories Hepatitis B and C Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
